Hypopituitarism secondary prevention

Revision as of 22:19, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Hypopituitarism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypopituitarism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypopituitarism secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypopituitarism secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypopituitarism secondary prevention

CDC on Hypopituitarism secondary prevention

Hypopituitarism secondary prevention in the news

Blogs on Hypopituitarism secondary prevention

Directions to Hospitals Treating Hypopituitarism

Risk calculators and risk factors for Hypopituitarism secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2] , Ahmed Elsaiey, MBBCH [3]

Overview

Secondary prevention may be done by long term monitoring of patients for complications of hormonal replacement therapy and by dose adjustments in stressful situations.

Secondary Prevention

References

  1. Harsch IA, Schuller A, Hahn EG, Hensen J (2010). "Cortisone replacement therapy in endocrine disorders - quality of self-care". J Eval Clin Pract. 16 (3): 492–8. doi:10.1111/j.1365-2753.2009.01149.x. PMID 20210825.

Template:WH Template:WS